Your browser doesn't support javascript.
loading
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.
Körper, Sixten; Grüner, Beate; Zickler, Daniel; Wiesmann, Thomas; Wuchter, Patrick; Blasczyk, Rainer; Zacharowski, Kai; Spieth, Peter; Tonn, Torsten; Rosenberger, Peter; Paul, Gregor; Pilch, Jan; Schwäble, Joachim; Bakchoul, Tamam; Thiele, Thomas; Knörlein, Julian; Dollinger, Matthias M; Krebs, Jörg; Bentz, Martin; Corman, Victor M; Kilalic, Dzenan; Schmidtke-Schrezenmeier, Gerlinde; Lepper, Philipp M; Ernst, Lucas; Wulf, Hinnerk; Ulrich, Alexandra; Weiss, Manfred; Kruse, Jan Matthias; Burkhardt, Thomas; Müller, Rebecca; Klüter, Harald; Schmidt, Michael; Jahrsdörfer, Bernd; Lotfi, Ramin; Rojewski, Markus; Appl, Thomas; Mayer, Benjamin; Schnecko, Philipp; Seifried, Erhard; Schrezenmeier, Hubert.
Afiliación
  • Körper S; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Grüner B; Division of Infectious Diseases, University Hospital and Medical Center Ulm, Ulm, Germany.
  • Zickler D; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Wiesmann T; Department of Anesthesiology and Intensive Care Medicine, Phillips-University Marburg, Marburg, Germany.
  • Wuchter P; Institute of Transfusion Medicine and Immunology, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, Medical Faculty Mannheim, Heidelberg University, Germany.
  • Blasczyk R; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
  • Zacharowski K; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe-University, Germany.
  • Spieth P; Department of Anesthesiology and Critical Care Medicine, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany.
  • Tonn T; Transfusion Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden and German Red Cross Blood Donation Service North-East gGmbH, Dresden, Germany.
  • Rosenberger P; Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Paul G; Department of Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Klinikum Stuttgart, Stuttgart, Germany.
  • Pilch J; Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University Hospital, Homburg/Saar, Germany.
  • Schwäble J; Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen, Frankfurt, Germany.
  • Bakchoul T; Institute of Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Thiele T; Institute of Transfusion Medicine, University Hospital Greifswald, Greifswald, Germany.
  • Knörlein J; Clinic of Anesthesiology and Intensive Care Medicine, University Medical Center of Freiburg, Freiburg, Germany.
  • Dollinger MM; Medical Clinic I, Klinikum Landshut, Landshut, Germany.
  • Krebs J; Clinic for Anesthesiology and Surgical Intensive Care Medicine, University of Mannheim, Mannheim, Germany.
  • Bentz M; Department of Internal Medicine III, Hospital of Karlsruhe, Karlsruhe, Germany.
  • Corman VM; Institute of Virology, Charité - University Medicine Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and German Centre for Infection Research, Berlin, Germany.
  • Kilalic D; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Schmidtke-Schrezenmeier G; Clinic of Internal Medicine II, Ulm University, Ulm, Germany.
  • Lepper PM; Department of Internal Medicine V - Pneumology, Allergology, Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
  • Ernst L; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Wulf H; Department of Anesthesiology and Intensive Care Medicine, Phillips-University Marburg, Marburg, Germany.
  • Ulrich A; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Weiss M; Department of Anesthesiology and Intensive Care Medicine, University Hospital Ulm, Ulm University, Ulm, Germany.
  • Kruse JM; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Burkhardt T; Transfusion Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden and German Red Cross Blood Donation Service North-East gGmbH, Dresden, Germany.
  • Müller R; Institute of Transfusion Medicine and Immunology, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, Medical Faculty Mannheim, Heidelberg University, Germany.
  • Klüter H; Institute of Transfusion Medicine and Immunology, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, Medical Faculty Mannheim, Heidelberg University, Germany.
  • Schmidt M; Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen, Frankfurt, Germany.
  • Jahrsdörfer B; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Lotfi R; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Rojewski M; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Appl T; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Mayer B; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
  • Schnecko P; Alcedis GmbH, Gießen, Germany.
  • Seifried E; Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen, Frankfurt, Germany.
  • Schrezenmeier H; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
J Clin Invest ; 132(24)2022 12 15.
Article en En | MEDLINE | ID: mdl-36326824

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article País de afiliación: Alemania